FDA Inspection 1258314 — Advanced Tactile Imaging, Inc.

Advanced Tactile Imaging, Inc. — FEI 3011278898

The FDA completed an inspection of Advanced Tactile Imaging, Inc. on Dec 6, 2024 in Ewing, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 6, 2024
Fiscal Year
2025
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Ewing, NJ (United States)

Citations

IDCFRDescription
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.